Literature DB >> 28416092

Cytokines and C-reactive protein alterations with respect to cognitive impairment in schizophrenia and bipolar disorder: A systematic review.

Błażej Misiak1, Bartłomiej Stańczykiewicz2, Kamila Kotowicz2, Janusz K Rybakowski3, Jerzy Samochowiec4, Dorota Frydecka2.   

Abstract

BACKGROUND: The aim of this article was to perform a systematic review of studies investigating the association between peripheral levels of cytokines and C-reactive protein (CRP), cytokine gene polymorphisms and cognition in patients with schizophrenia and bipolar disorder (BD).
METHODS: The following databases: PubMed, CINAHL Complete, Academic Search Complete, ERIC and Health Source: Nursing/Academic Edition databases were searched according to the PRISMA guidelines. We included studies that investigated the association between peripheral levels of CRP and cytokines, cytokine gene polymorphisms and cognitive performance in schizophrenia and/or BD patients. Subsequently, quality assessment of eligible publications was performed. Results were synthesized by discussing main findings around correlations between inflammatory markers and cognition.
RESULTS: Most consistent results indicate worse cognitive performance in schizophrenia patients with higher CRP levels. Less consistent evidence suggests better cognitive functioning of schizophrenia patients with higher levels of tumour necrosis factor-α (TNF-α). Evidence for the involvement of other cytokines in cognitive impairment in patients with schizophrenia is less convincing due to discordant results or scarcity of studies. Due to low number of studies, it is difficult to draw conclusions on the involvement of CRP and cytokine alterations in the development of cognitive deficits in BD. Single studies suggest the role of CRP, interleukin(IL)-1 receptor antagonist, IL-6 and TNF-α with its receptors in the development of cognitive impairment in BD.
CONCLUSIONS: Peripheral inflammation might be related to cognitive deficits in schizophrenia and BD. Unequivocal conclusions cannot be made due to methodological heterogeneity and low number of studies investigating particular cytokines.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bipolar disorder; Cognitive performance; Cytokines; Inflammation; Interleukins; Schizophrenia

Mesh:

Substances:

Year:  2017        PMID: 28416092     DOI: 10.1016/j.schres.2017.04.015

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  41 in total

Review 1.  Neuroinflammation and Schizophrenia.

Authors:  Peter F Buckley
Journal:  Curr Psychiatry Rep       Date:  2019-07-03       Impact factor: 5.285

2.  Salsalate as an adjunctive treatment for psychopathology and cognition in patients with schizophrenia: a pilot study.

Authors:  Yanli Luo; Fang Liu; Radhika Natarajan; Nawras Shukair; Paul Copeland; Xiaoduo Fan
Journal:  Int Clin Psychopharmacol       Date:  2018-03       Impact factor: 1.659

3.  Inflammation in individuals with schizophrenia - Implications for neurocognition and daily function.

Authors:  Sophia Kogan; Luz H Ospina; David Kimhy
Journal:  Brain Behav Immun       Date:  2018-09-12       Impact factor: 7.217

4.  Insomnia and suicidal ideation in nonaffective psychosis.

Authors:  Brian J Miller; Carmen B Parker; Mark H Rapaport; Peter F Buckley; William V McCall
Journal:  Sleep       Date:  2019-02-01       Impact factor: 5.849

5.  Avoidance of accelerated aging in schizophrenia?: Clinical and biological characterization of an exceptionally high functioning individual.

Authors:  Barton W Palmer; Raeanne C Moore; Lisa T Eyler; Luz L Pinto; Elyn R Saks; Dilip V Jeste
Journal:  Schizophr Res       Date:  2017-08-08       Impact factor: 4.939

6.  Correlations between Body Mass Index, Plasma High-Sensitivity C-Reactive Protein and Lipids in Patients with Schizophrenia.

Authors:  Ted Boozalis; Sridevi Devaraj; Olaoluwa O Okusaga
Journal:  Psychiatr Q       Date:  2019-03

7.  Evaluating the Hypothesis That Schizophrenia Is an Inflammatory Disorder.

Authors:  Brian J Miller; David R Goldsmith
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-11-05

8.  The effect of adjunctive telmisartan treatment on psychopathology and cognition in patients with schizophrenia.

Authors:  X Fan; X Song; M Zhao; L F Jarskog; R Natarajan; N Shukair; O Freudenreich; D C Henderson; D C Goff
Journal:  Acta Psychiatr Scand       Date:  2017-08-29       Impact factor: 6.392

9.  Restoration of Cognitive Performance in Mice Carrying a Deficient Allele of 8-Oxoguanine DNA Glycosylase by X-ray Irradiation.

Authors:  Tim Hofer; Nur Duale; Martine Muusse; Dag Marcus Eide; Hildegunn Dahl; Fernando Boix; Jannike M Andersen; Ann Karin Olsen; Oddvar Myhre
Journal:  Neurotox Res       Date:  2017-11-03       Impact factor: 3.911

Review 10.  The impact of inflammation on neurocognition and risk for psychosis: a critical review.

Authors:  Sophia Kogan; Luz H Ospina; Vijay A Mittal; David Kimhy
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-10-16       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.